Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.

Détails

Ressource 1Télécharger: BIB_4897A3C40E3F.P001.pdf (394.06 [Ko])
Etat: Public
Version: de l'auteur⸱e
Licence: Non spécifiée
ID Serval
serval:BIB_4897A3C40E3F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.
Périodique
Emerging Infectious Diseases
Auteur⸱e⸱s
Kenfak-Foguena A., Schöni-Affolter F., Bürgisser P., Witteck A., Darling K.E., Kovari H., Kaiser L., Evison J.M., Elzi L., Gurter-De La Fuente V., Jost J., Moradpour D., Abravanel F., Izpopet J., Cavassini M.
Collaborateur⸱rice⸱s
Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland
ISSN
1080-6059 (Electronic)
ISSN-L
1080-6040
Statut éditorial
Publié
Date de publication
2011
Volume
17
Numéro
6
Pages
1074-1078
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
We screened 735 HIV-infected patients in Switzerland with unexplained alanine aminotransferase elevation for hepatitis E virus (HEV) immunoglobulin G. Although HEV seroprevalence in this population is low (2.6%), HEV RNA can persist in patients with low CD4 cell counts. Findings suggest chronic HEV infection should be considered as a cause of persistent alanine aminotransferase elevation.
Mots-clé
Antibodies, Viral/blood, CD4 Lymphocyte Count, Chronic Disease, Female, HIV Infections/complications, Hepatitis E/complications, Hepatitis E/epidemiology, Hepatitis E virus/genetics, Hepatitis E virus/immunology, Humans, Immunoglobulin G/blood, Male, Risk Factors, Seroepidemiologic Studies, Switzerland/epidemiology, Viral Load
Pubmed
Web of science
Open Access
Oui
Création de la notice
08/11/2011 17:40
Dernière modification de la notice
21/11/2022 9:24
Données d'usage